SecBot SecBot
SECBOTREPLAY Home › Report › KPTI

KPTI · Six KPTI insiders, including CEO Richard Paulson, sold shares on May 14…

Karyopharm Therapeutics Inc. · CLUSTER filed May 15, 2026 at 16:08 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed May 15, 2026 at 16:08 ET

Six KPTI insiders, including CEO Richard Paulson, sold shares on May 14 (the same day as Q1 earnings), totaling $35,000 in open-market sales. The dollar value is 0.02% of the $185M market cap, well below the 0.1% materiality floor. This is a routine cluster timed to a blackout-window opening, not an informed bearish signal. Separately, a director received a $0 grant of 15,508 shares on May 21 as non-cash compensation.

  • Six insiders, including the CEO and CFO, sold shares on May 14 at $9.50, totaling $35,000.
  • Sales represent 0.02% of $185M market cap, immaterial by all proportionality standards.
  • Director Barry Greene received a 15,508-share $0 grant on May 21 (non-cash compensation).
  • Sales occurred on earnings day (Q1 2026 results filed May 14), consistent with a blackout-window opening.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access